Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...

Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 MonthsAccelerated pathway: ...

Aragen's new cell line development and early manufacturing platform, CHOMax, can cut timelines to approximately 10 months.

BOSTON & SAN CARLOS, Calif.--(BUSINESS WIRE)--Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a licensing agreement for its CHO Edge System ...

In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...